[151]
VHA/DOD CLINICAL PRACTICE GUIDELINE FOR DIAGNOSIS AND MANAGEMENT ...
[363,8 KB]
From [www.pbm.va.gov] Last viewed: 21.09.2006
VHA/DOD CLINICAL PRACTICE GUIDELINE FOR
DIAGNOSIS AND MANAGEMENT OF
HYPERTENSION
IN THE PRIMARY CARE SETTING
Veterans Health Administration
Department of Defense
Page 2
Prepared by:
The Hypertension Workgroup
with support from:
The Office of Performance and Quality, VHA Headquarters, Washington, DC
&
Quality Management Directorate, United States Army MEDCOM
&
The External Peer Review Program
Contractor and Subcontractor:
West Virginia Medical Institute, Inc.
Birch & Davis Associates, Inc.
Contract number: V101(93)P-1633
May 1999
Version 1.0
Page 3
CLINICAL PRACTICE GUIDELINE FOR DIAGNOSIS AND MANAGEMENT OF
HYPERTENSION
IN THE PRIMARY CARE SETTING
TABLE OF CONTENTS
Page 4
VHA/DoD Clinical ...
[152]
Hypertension Disease Deaths in California, 1999-2002
[479,7 KB]
From [www.dhs.ca.gov] Last viewed: 21.09.2006
__
STATE OF CALIFORNIA
HEALTH AND HUMAN SERVICES AGENCY
DEPARTMENT OF HEALTH SERVICES
Arnold Schwarzenegger, Governor
Kimberly Belshé, Secretary
Sandra Shewry, Director
Hypertension Disease Deaths in California,
1999-2002
By Daniel H. Cox
Introduction
Hypertension disease, also known as essential (primary) hypertension and
hypertensive renal disease or high blood pressure, is a leading cause of death
in the United States and in California. Hypertension disease increases the risk
for heart disease and stroke, two other leading causes of death. Approximately
one in four American adults have hypertension disease and more than
31 percent of those affected are unaware of their condition.
1
In 2002 there
were 20,261 hypertension disease deaths in the United States; 2,330 of those
deaths occurred in California.
2 ...
[153]
Hypertension Disease Deaths in California, 1999-2002
[479,7 KB]
From [www.dhs.ca.gov] Last viewed: 21.09.2006
__
STATE OF CALIFORNIA
HEALTH AND HUMAN SERVICES AGENCY
DEPARTMENT OF HEALTH SERVICES
Arnold Schwarzenegger, Governor
Kimberly Belshé, Secretary
Sandra Shewry, Director
Hypertension Disease Deaths in California,
1999-2002
By Daniel H. Cox
Introduction
Hypertension disease, also known as essential (primary) hypertension and
hypertensive renal disease or high blood pressure, is a leading cause of death
in the United States and in California. Hypertension disease increases the risk
for heart disease and stroke, two other leading causes of death. Approximately
one in four American adults have hypertension disease and more than
31 percent of those affected are unaware of their condition.
1
In 2002 there
were 20,261 hypertension disease deaths in the United States; 2,330 of those
deaths occurred in California.
2 ...
[154]
Marker for Essential Hypertension Jules Puschett
[19,5 KB]
From [129.81.233.2] Last viewed: 21.09.2006
Tulane University
Office of Technology Transfer and Business Development
1430 Tulane Ave TB-32
New Orleans, LA 70112
504-988-6962 / 988-2473 fax
Marker for Essential Hypertension
Jules Puschett
BACKGROUND
Elevated blood pressure or hypertension has long been recognized as a health problem
and is frequently asymptomatic. Essential hypertension can be divided into two broad
categories, volume expansion hypertension and vasoconstriction hypertension . Volume
expansion hypertension accounts for 40% of the hypertensive population and has
important implications in certain demographic groups such as African-Americans, the
obese, and the elderly. It could also have implications for diabetics in their disease
process.
DESCRIPTION OF THE INVENTION
Tulane researchers have conducted studies on etiologic factors in forms of hypertension
and identified a "marker" ...
[155]
Algorithm for Treatment of Hypertension--Sample Clinical Tool for ...
[22,8 KB]
From [www.ashp.org] Last viewed: 21.09.2006
L
IFESTYLE
M
ODIFICATIONS
Not at Goal Blood Pressure (<140/90 mmHg)
(<130/80 mmHg for patients with diabetes or chronic kidney disease)
Without Compelling Indications
With Compelling
Indications
I
NITIAL
D
RUG
C
HOICES
Stage 1
Hypertension
(SBP 140–159 or
DBP 90–99
mmHg)
Thiazide-type
diuretics for most.
May consider
ACEI, A2RA, BB,
CCB, or com-
bination.
Stage 2
Hypertension
(SBP >160 or DBP
>100 mmHg)
Two-drug com-
bination for most
(usually thiazide-
type diuretic and
ACEI, or A2RA, or
BB, or CCB)
Drug(s) for the
Compelling
Indications
(See Table on Com-
pelling Indications for
Drug Classes based
on Comorbid
Conditions [Table 2])
Other antihypertensive
drugs (diuretics, ACEI,
...
[156]
Innoviant - Facts about Hypertension
[182,8 KB]
From [www.innoviant.com] Last viewed: 21.09.2006
335
Journal of Manipulative and Physiological Therapeutics
Volume 24 • Number 5 • June 2001
0161-4754/2001/$35.00 + 0 76/1/115263 © 2001 JMPT
Medically Supervised Water-only Fasting in the Treatment of Hypertension
Alan Goldhamer, DC,
a
Douglas Lisle, PhD,
b
Banoo Parpia, PhD,
c
Scott V. Anderson, MD,
d
and T. Colin Campbell, PhD
e
INTRODUCTION
Hypertension -related diseases are the most common causes
of morbidity and mortality among industrially advanced soci-
eties.
1
Each year in the United States, there are 500,000 victims
of stroke. Hypertension is the major cause in these incidents,
one third of which are fatal.
2
Hypertension also is thought to be
the most easily controlled, preventable factor in congestive
heart failure, a disease involved ...
[157]
Guidelines for management of hypertension: report of the fourth ...
[598,0 KB]
From [www.bhsoc.org] Last viewed: 21.09.2006
BRITISH HYPERTENSION SOCIETY GUIDELINES
Guidelines for management of
hypertension : report of the fourth working
party of the British Hypertension Society,
2004—BHS IV
B Williams
1
, NR Poulter
2
, MJ Brown
3
, M Davis
4
, GT McInnes
5
, JF Potter
6
, PS Sever
2
and
S McG Thom
2
1
Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, University of
Leicester, Leicester, UK;
2
International Centre for Circulatory Health, Imperial College London & St Mary’s
Hospital, London, UK;
3
Clinical Pharmacology Unit, Addenbrooke’s Hospital, University of Cambridge,
Cambridge, UK;
4
Moorfield House Surgery, Garforth, Leeds, UK;
5
Section of Clinical Pharmacology ...
[158]
GMS CONTRACT DATA ENTRY FOR HYPERTENSION
[851,5 KB]
From [www.show.scot.nhs.uk] Last viewed: 21.09.2006
© Crown Copyright 2003
1
GMS CONTRACT DATA ENTRY FOR
HYPERTENSION
2.
Click on
Encounter
1.
Highlight the
patient’s
name and
press F8
3.
Click on Care
Management
4.
Click on SPICE
button
Page 2
GMS CONTRACT DATA ENTRY FOR HYPERTENSION
QUICK GUIDE
© Crown Copyright 2003
2
The 1
st
SPICE Index is displayed:
The SPICE Hypertension screen is displayed:
5.
Click
Hypertension
button
6.
Enter data in
some or all of
the fields (as
Displays certification
logo and details of
form designer
Displays information
about the disease area
Returns to 1
st
SPICE
Index
required)
7.
Click on Recall
button to set a
recall (steps 7-13
...
[159]
Guidelines for management of hypertension: report of the fourth ...
[598,0 KB]
From [www.sld.cu] Last viewed: 21.09.2006
BRITISH HYPERTENSION SOCIETY GUIDELINES
Guidelines for management of
hypertension : report of the fourth working
party of the British Hypertension Society,
2004—BHS IV
B Williams
1
, NR Poulter
2
, MJ Brown
3
, M Davis
4
, GT McInnes
5
, JF Potter
6
, PS Sever
2
and
S McG Thom
2
1
Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, University of
Leicester, Leicester, UK;
2
International Centre for Circulatory Health, Imperial College London & St Mary’s
Hospital, London, UK;
3
Clinical Pharmacology Unit, Addenbrooke’s Hospital, University of Cambridge,
Cambridge, UK;
4
Moorfield House Surgery, Garforth, Leeds, UK;
5
Section of Clinical Pharmacology ...
[160]
4.5. Number of Persons With Hypertension - Age By Gender, and ...
[19,7 KB]
From [www.state.hi.us] Last viewed: 21.09.2006
0-14
15-17
18-24
25-34
35-44
45-54
55-64
65-74
75+
Gender
Male
*
*
1,217
3,576
11,473
20,522
23,459
16,691
15,300
92,335
Female
*
*
1,121
2,363
8,819
16,112
23,999
18,683
25,795
96,971
Ethnicity/Race
Caucasian
*
*
590
1,165
3,366
6,670
12,126
7,678
9,139
40,794
Hawaiian
*
*
*
987
5,138
7,040
9,058
4,831
2,950
30,615
Chinese
--
--
--
*
1,136
3,378
2,122
*
*
12,666
Filipino
--
--
511
1,414
4,183
7,931
8,644
5,919
5,230
33,832
Japanese
*
--
*
938
4,143
9,638
12,641
12,696
17,308 ...
[161]
4.5. Number of Persons With Hypertension - Age By Gender, and ...
[19,6 KB]
From [www.state.hi.us] Last viewed: 21.09.2006
0-14
15-17
18-24
25-34
35-44
45-54
55-64
65-74
75+
Gender
Male
166*
410
1,358
3,891
10,531
17,747
17,034
14,797
12,255
78,189
Female
256*
13*
744
1,693
5,752
16,231
13,856
18,331
18,984
75,860
Ethnicity/Race
Caucasian
167*
--
371*
711
1,623
6,919
6,430
6,063
5,550
27,834
Hawaiian
155*
102*
598
1,550
4,485
5,323
6,084
4,624
2,589
25,510
Chinese
--
--
--
31*
891
1,432
1,895
2,144
3,794
10,187
Filipino
58*
145*
209*
843
2,977
5,906
4,904
4,715
3,843
23,600
Japanese
43*
178*
265*
868
4,604
...
[162]
Part 1: Detection and Diagnosis of Hypertension
[327,7 KB]
From [www.health.gov.bc.ca] Last viewed: 21.09.2006
Part I: Detection and Diagnosis of Hypertension
Scope
This guideline applies to the detection and diagnosis of hypertension (HT) in non-pregnant adults (aged
19 years and older). This guideline is to be used with “Part II: Treatment of Essential Hypertension ”.
Hypertension in each category is defined by an elevation of the systolic or diastolic threshold or both.
R
ECOMMENDATION
1:
Recommended technique
Details of proper technique and equipment are included on page 2. Blood pressure (BP) measurement
should be rigorous in those patients who:
• have known or newly detected elevated BP;
• have cardiovascular target organ damage;*
• have other risk factors; or
• are receiving antihypertensive therapy.
R
ECOMMENDATION
2:
Follow a plan
Blood pressure is noted to be > 140/90
• take at least two readings ...
[163]
Hypertension Prevalence in Van, Turkey-1997
[68,6 KB]
From [ejm.yyu.edu.tr] Last viewed: 21.09.2006
Eastern Journal of Medicine 6 (1): 22-25, 2001
Erkoç et al.
22
Objective: The aim was to investigate the prevalence
of hypertension in Van.
Method: A total of 2010 subjects (586 male, mean age:
44.8 ± 14.9; 1424 female, mean age: 39.1 ± 14.1) between
the ages of 20-74, were sampled from a target
population of 315,866 according to systematic
sampling technique. Blood pressure of each participant
was measured by using Erka
®
sphygmomanometer for
two times with a 3 minutes interval by a physician and
an average was obtained.
Results: Hypertension prevalence was 34.9 % (males:
33.3 %, females: 35.5 %, p> 0.05) according to 140/90
mmHg criterium and 19.1 % (males: 14.5 %, females:
21.0 %, p < 0.001) according to 160/95 mmHg criterium.
Mean systolic and diastolic blood pressures were
129.97± 27.78 mmHg (95% CI:128.7, ...
[164]
HYPERTENSION
[71,3 KB]
From [www.capegateway.gov.za] Last viewed: 21.09.2006
HYPERTENSION
National
programme for
control and
management at
primary level
Page 2
1
INTRO-
DUCTION
Hypertension is a major public health prob-
lem in virtually all parts of the world, as well as
in South Africa.
A consistent blood pressure above 140/90
mmHg carries an increased risk for hyper-
tension-associated diseases such as strokes
and heart attacks. The World Health Organi-
sation (WHO) defines being hypertensive as
having a blood pressure higher than 160/95
mmHg. The health risk a given level of blood
pressure presents is magnified by risk factors:
e.g. obesity, unhealthy nutrition, diabetes
mellitus, excessive alcohol intake, physical
inactivity, and smoking.
These risk factors are primarily the result of
following an unhealthy lifestyle and emphasise
the societal character of the problem. Effective ...
[165]
Pulmonary hypertension
[317,6 KB]
From [www.fleshandbones.com] Last viewed: 21.09.2006
277
INTRODUCTION
Pulmonary hypertension is a progressive disease that ultimately leads to right-ventricular
failure and death. It is characterized by an elevated pulmonary artery pressure and
pulmonary vascular resistance.
The incidence of primary pulmonary hypertension (PPH) is estimated to be 1–2/
1000 000/year and approximately 6% appear to be familial. There is a preponderance of
females among PPH patients with a ratio of female to male varying between 1.7 and
3.5:1.
DEFINITION
Pulmonary hypertension is defined as an elevated mean pulmonary artery pressure of
25 mmHg or greater at rest or 30 mmHg with exercise. In 1998, the World Health
Organization set out new guidelines for the re-classification of pulmonary hypertension
(Boxes 19.1 & 19.2).
PATHOLOGY
Pulmonary arteriopathy is characterized by medial hypertrophy, intimal proliferation,
concentric ...
[166]
P&T Digest Hypertension
[1735,5 KB]
From [www.ptcommunity.com] Last viewed: 21.09.2006
P
&
T D
IGEST
A PEER-REVIEWED COMPENDIUM OF FORMULARY CONSIDERATIONS
• Prevalence
and economic
implications
• Summary
of JNC-7 guidelines
• Trials underlying
JNC-7 guidelines
• Implications
of uncontrolled
hypertension
• Drug-therapy review
• Recommendations
for combination therapy
• NCQA standards and
quality measurement
•
Adherence to therapy
•
Formulary status of
antihypertensive agents
Vol.28,No.8
August 2003
S U P P L E M E N T T O
H
YPERTENSION
Continuing education credit for physicians and pharmacists
is sponsored byThe Chatham Institute
This program is supported by an unrestricted educational grant
from AstraZeneca
Pharmacy and Therapeutics
A Peer-Reviewed Journal for Managed Care
and Hospital Formulary ...
[167]
OBSTETRICAL GUIDELINE Chronic Hypertension
[220,8 KB]
From [www.sld.cu] Last viewed: 21.09.2006
OB-Chronic Hypertension
1 of 6
OBSTETRICAL GUIDELINE
Chronic Hypertension
Drafted:
06/30/03
Peer Reviewed:
04/29/04
Finalized:
05/27/04
I. Definition, Assessment, and Diagnosis:
A. Definition:
1. Chronic hypertension is defined as hypertension (blood pressure > 140/90) present
before the pregnancy.
2. Diagnosed before the 20
th
week of gestation of pregnancy.
3. Persists more than 12 weeks postpartum.
B. Assessment: Documented history of high blood pressure pre- pregnancy. Persistent
elevation of blood pressure (at least 140/90mm Hg) on two separate occasions more than 24
hours apart before the 20
th
week of gestation.
1. Other changes suggestive in the presence of chronic hypertension :
a. Retinal changes on funduscopic examination
b. Cardiac enlargement on chest x-ray and ECG
c. Presence ...
[168]
Hypertension – management of hypertension in adults in primary care
[163,2 KB]
From [www.nice.org.uk] Last viewed: 21.09.2006
Issue date: August 2004
Quick reference guide
Hypertension – management
of hypertension in adults in
primary care
Clinical Guideline 18
Developed by the Newcastle Guideline Development and
Research Unit
Page 2
This guidance is written in the following context.
This guidance represents the view of the Institute, which was arrived at after careful consideration
of the evidence available. Health professionals are expected to take it fully into account when
exercising their clinical judgement. The guidance does not, however, override the individual
responsibility of health professionals to make decisions appropriate to the circumstances of the
individual patient, in consultation with the patient and/or guardian or carer.
National Institute for
Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V ...
[169]
Dermal ulcers and hypertension in salt workers
[26,8 KB]
From [www.ias.ac.in] Last viewed: 21.09.2006
RESEARCH COMMUNICATIONS
CURRENT SCIENCE, VOL. 87, NO. 8, 25 OCTOBER 2004
Dermal ulcers and hypertension in salt
workers
Kripa Ram Haldiya
1,
*, Murli L. Mathur
1
,
Raman Sachdev
1
and Habibulla N. Saiyed
2
1
Desert Medicine Research Centre (ICMR), Jodhpur 342 005, India
2
National Institute of Occupational Health (ICMR), Meghani Nagar,
Ahmedabad 380 816, India
In the process of salt manufacture, brine rich in salt is
filled in broad pans exposed to direct sunlight. Brine
workers keep their feet in the brine while working in
these pans. They frequently have traumatic ulcers on
their feet and hands. The aim of the present communica-
tion was to find out if prevalence of hypertension and
blood pressure in brine workers was affected by the
presence of ulcers ...
[170]
Pharmacogenomics and Hypertension Draft Protocols
[830,4 KB]
From [medicine.ucsd.edu] Last viewed: 21.09.2006
Pharmacogenomics Protocol #030199 – Drs. O’Connor and Bhatnagar
Original -6/5/03
Revision- 6/8/04
Pharmacogenomics and Hypertension
Draft Protocols
June 17, 2004
(1) Mail Recruitment
• HTN Clinical lab
(2) Consent and Sample Returned
• HTN Clinical lab
(3) DNA Extraction and Quantification
• Stein HTN lab
(4) DNA Prep for Genotyping
• Genomics Core/ Stein HTN lab
(
5) Genotyping: Results
• Bioinfomatics core
Page 2
Pharmacogenomics Protocol #030199 – Drs. O’Connor and Bhatnagar
Original -6/5/03
Revision- 6/8/04
(1) Protocol for Mail Recruitment
Pharmacogenomics #030199
Drs. O’Connor and Bhatnagar
An electronic system needs to be developed to track the following steps.
Each initial mailed packet should contain the following:
• Revised (5/04) Recruitment letter
• Revised (5/04) Consent ...
[171]
Hypertension in Children
[162,2 KB]
From [www.mcph.org] Last viewed: 21.09.2006
Hypertension in Children
Selected excerpts from “The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and
Adolescents,” Pediatrics, Vol. 114, No. 2, August 2004
Definition of Hypertension
• Hypertension is defined as average SBP and/or diastolic BP (DBP) that 95th percentile for
gender, age, and height on =3 occasions.
• Prehypertension in children is defined as average SBP or DBP levels that are =90th
percentile but <95th percentile; as with adults, adolescents with BP levels =120/80 mm Hg
should also be considered prehypertensive.
• A patient with BP levels >95th percentile in a physician’s office or clinic, who is
normotensive outside a clinical setting, has “white-coat hypertension .” Ambulatory BP
monitoring (ABPM) is usually required to make this diagnosis.
THERAPEUTIC LIFESTYLE CHANGES
•
Weight reduction ...
[172]
Effectiveness Matters 4(2) - Drug treatment of hypertension in ...
[118,2 KB]
From [www.york.ac.uk] Last viewed: 21.09.2006
EFFECTIVENESS
EFFECTIVENESS
Matters
Matters
NHS CENTRE FOR REVIEWS AND DISSEMINATION
Effectiveness Matters is based upon the findings of
recent high quality systematic reviews. In this issue we
explore the evidence for the drug treatment of
hypertension in older people with the aim of
preventing cardiovascular disease.
Vol 4, Issue 2, October 1999
s
Hypertension is very common,
occurring in over 50% of older
people, and is a major risk factor
for stroke and ischaemic heart
disease.
s
Drug treatment of hypertension in
older people saves lives and
prevents unnecessary morbidity.
s
Treating isolated systolic
hypertension also saves lives.
s
There is strong evidence to support
the use of diuretics as first line
agents.
s
Antihypertensive treatments are
most ...
[173]
Hypertension Guideline 2004: A Brief Overview
[546,9 KB]
From [www.qmo.amedd.army.mil] Last viewed: 21.09.2006
Hypertension Guideline 2004:
A Brief Overview
Peter A. Glassman MBBS, MSc
Staff Physician, VA Greater Los Angeles
Member, HTN Faculty Advisory Committee
Page 2
Key Elements
“ Speed to Target ”
S creen
P revent
E ncourage
E valuate
D rug(s) Therapy
T itrate
O rganize
T ARGET
Page 3
SPEED
Page 4
Page 5
Screen Now
Assess blood pressure in adults
Page 6
Screen Annually
Incidence Rises Over Time
1976-98 Cumulative Incidence of HTN
in Women and Men Aged 65 Years
1976
1976 - - 98 Cumulative Incidence of HTN
98 Cumulative Incidence of HTN
in Women and Men Aged 65 Years
in Women and Men Aged 65 Years
JAMA.2002;287:1003 ...
[174]
Hypertension
[38,2 KB]
From [www.healthandwelfare.idaho.gov] Last viewed: 21.09.2006
Hypertension
HEALTHY HEARTS SERIES: BLOOD PRESSURE
Who is at risk?
Proportion of
Idahoans who’ve
been told by a
health professional
they have high
blood pressure*:
Age 65 and over:
49%
Age 55 and over:
42%
Less than high
school education:
32%
Household income
less than $20,000:
29%
Adult men:
24%
Adult women:
23%
Hispanic adults:
18%
Ages 18 to 24:
8%
High Blood Pressure: New Guidelines
Cardiovascular disease, the leading cause of death in Idaho
In 1996, 2,359 persons in Idaho died of diseases of the heart and 708
persons died of cerebrovascular disease. Such diseases often result
from the complications of high blood pressure.
• From 1993-1995, the age-adjusted rate of cerebrovascular diseases,
which includes stroke, ...
[175]
Topic: Renovascular Hypertension
[249,0 KB]
From [www.sirweb.org] Last viewed: 21.09.2006
Topic: Renovascular
Hypertension
Hypertension affects an estimated 10 percent to
25 percent of the U.S. population. Of these, the
great majority have primary elevation of blood
pressure, which can be ameliorated with pharma-
cological treatment. A subset of patients — an
estimated 3 percent to 8 percent — have sec-
ondary hypertension attributable to renovascular
disease caused by narrowing of the renal artery.
1-2
Diminished perfusion to the kidney results in
increased renin secretion and production of
angiotensin II, leading to systemic vasoconstriction
and retention of salt and water. Renovascular hyper-
tension may be present when systemic blood pres-
sure is normal.
Renovascular hypertension has emerged as a
major cause of end-stage renal disease, especially in
the elderly. As the U.S. population ages, the num-
ber of individuals with atherosclerotic ...
[176]
Hypertension GuideD080503
[192,0 KB]
From [www.pplusic.com] Last viewed: 21.09.2006
Guidelines are designed to assist clinicians by providing a framework for the evaluation and treatment of patients. These guidelines
outline the preferred approach for most patients. They are not intended to replace a clinician's judgment or to establish a protocol
for all patients. It is understood that some patients will not fit the clinical condition contemplated by a guideline and that a guide-
line will rarely establish the only appropriate approach to a problem.
The purpose of treating hypertension is to reduce the incidence of stroke, MI, renal failure and heart failure. Unless
contraindicated or there is a compelling indication to use other medication, low dose diuretic therapy should be used
as first or second line therapy.
1. ESTABLISHING THE DIAGNOSIS
The diagnosis of hypertension should be based on the confirmation of elevated readings on two or more subsequent
visits to the physician or health ...
[177]
Effect of Total Obesity and Abdominal Obesity on Hypertension ...
[298,7 KB]
From [export.musc.edu] Last viewed: 21.09.2006
Introduction
Obesity in the United States has reached epidemic proportions and its
prevalence continues to rise as Americans become less physically
active and more sedentary. Among adolescents, African Americans
exhibit the highest rates of obesity. Based on data from the 1999-2000
National Health and Nutritional Examination Survey (NHANES III) it
is estimated that the prevalence of obesity in African American
adolescents (23.6%) is significantly higher than their non-Hispanic
white counterparts (12.7%) and has increased by 13.4% between 1988-
1994 and 1999-2000.
As obesity among African Americans
adolescents continues to increase the rate of metabolic abnormalities,
cardiovascular disease and type II diabetes among this group will
mimic this increasing trend.
Not only is obesity a known independent risk factor for the
development of cardiovascular disease (CVD), but it tends to cluster
with other ...
[178]
Ambulatory blood pressure monitoring and “white coat” hypertension ...
[132,3 KB]
From [www.mja.com.au] Last viewed: 21.09.2006
MJA
Vol 176
17 June 2002
571
EDITORIALS
indicated widespread damage and evidence of increased
endothelial activity ranging from scarring through to nuclear
atypia.
There are important lessons to be learned. Exposure of
the thyroid gland to any irradiation requires lifelong supervi-
sion and introspection. This should include high-resolution
ultrasound. The extent of thyroid exposure to radiation may
be arcane and not recalled when the highlight of the history
is focused on areas away from the gland. Most radiation
oncology units in Australia have follow-up facilities, but the
duration of follow-up is not uniform. Moreover, patients
travel and disperse, so their supervision will be most likely
carried out by doctors with less experience of such patients.
In this regard the American Thyroid Association publishes
an excellent information sheet for patients.
4 ...
[179]
Pulmonary arterial hypertension: a new era in management
[511,3 KB]
From [www.mja.com.au] Last viewed: 21.09.2006
564
MJA
Vol 178
2 June 2003
CLINICAL UPDATE
The Medical Journal of Australia ISSN: 0025-729X 2 June
2003 178 12 564-567
©The Medical Journal of Australia 2003 www.mja.com.au
Clinical Update
P
ULMONARY ARTERIAL HYPERTENSION
(PAH) is gener-
ally considered a rare and rapidly lethal condition with poor
prognosis and few or no treatment options.
1,2
However,
PAH is a generic term that includes elevated pulmonary
vascular resistance due to a wide range of causes (Box 1).
3
PAH is defined as a mean pulmonary arterial pressure of
>25 mmHg at rest and >30 mmHg with exercise. Primary
pulmonary hypertension has an estimated incidence of 2 per
million population (possibly higher), with PAH associated
with other diseases showing a higher incidence.
3
PAH is
often not detected until the late and highly ...
[180]
Medically Supervised Water-only Fasting in the Treatment of ...
[53,1 KB]
From [www.healthpromoting.com] Last viewed: 21.09.2006
335
Journal of Manipulative and Physiological Therapeutics
Volume 24 • Number 5 • June 2001
0161-4754/2001/$35.00 + 0 76/1/115263 © 2001 JMPT
Medically Supervised Water-only Fasting in the Treatment of Hypertension
Alan Goldhamer, DC,
a
Douglas Lisle, PhD,
b
Banoo Parpia, PhD,
c
Scott V. Anderson, MD,
d
and T. Colin Campbell, PhD
e
INTRODUCTION
Hypertension -related diseases are the most common causes
of morbidity and mortality among industrially advanced soci-
eties.
1
Each year in the United States, there are 500,000 victims
of stroke. Hypertension is the major cause in these incidents,
one third of which are fatal.
2
Hypertension also is thought to be
the most easily controlled, preventable factor in congestive
heart failure, a disease involved ...